Published in J Biol Chem on April 23, 2001
Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J (2007) 9.65
The calpain system and cancer. Nat Rev Cancer (2011) 2.10
Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol (2004) 2.08
Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem (2004) 1.81
Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: implications for neurodegeneration and cell death. Autophagy (2007) 1.79
TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. J Biol Chem (2006) 1.75
Calpain regulates neutrophil chemotaxis. Proc Natl Acad Sci U S A (2003) 1.73
Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell Signal (2007) 1.65
Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol (2002) 1.64
Raf-1 regulates Rho signaling and cell migration. J Cell Biol (2005) 1.58
Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins. Mol Cell Biol (2008) 1.50
Integrin activation by Fam38A uses a novel mechanism of R-Ras targeting to the endoplasmic reticulum. J Cell Sci (2010) 1.45
Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J Exp Med (2010) 1.43
Paxillin phosphorylation controls invadopodia/podosomes spatiotemporal organization. Mol Biol Cell (2007) 1.39
m-Calpain is required for preimplantation embryonic development in mice. BMC Dev Biol (2006) 1.37
Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. Mol Cell Biol (2005) 1.35
Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling. J Cell Physiol (2008) 1.34
The MEK1 scaffolding protein MP1 regulates cell spreading by integrating PAK1 and Rho signals. Mol Cell Biol (2005) 1.34
Brain-derived neurotrophic factor and epidermal growth factor activate neuronal m-calpain via mitogen-activated protein kinase-dependent phosphorylation. J Neurosci (2010) 1.33
PAK1-mediated activation of ERK1/2 regulates lamellipodial dynamics. J Cell Sci (2008) 1.32
Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation. Mol Cell Biol (2006) 1.31
MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J (2003) 1.27
17-Beta-estradiol increases neuronal excitability through MAP kinase-induced calpain activation. Proc Natl Acad Sci U S A (2009) 1.24
Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration. J Cell Biol (2001) 1.22
Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion. Mol Cell Biol (2004) 1.21
MAPK activation modulates permeability of isolated rat alveolar epithelial cell monolayers following cyclic stretch. PLoS One (2010) 1.15
Asymmetric localization of calpain 2 during neutrophil chemotaxis. Mol Biol Cell (2006) 1.14
HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms. Biophys J (2003) 1.14
Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease. J Clin Invest (2011) 1.11
Calpain is required for normal osteoclast function and is down-regulated by calcitonin. J Biol Chem (2006) 1.10
Location, location, location: altered transcription factor trafficking in neurodegeneration. J Neuropathol Exp Neurol (2007) 1.09
Calpain 2 controls turnover of LFA-1 adhesions on migrating T lymphocytes. PLoS One (2010) 1.08
TRPM7 activates m-calpain by stress-dependent stimulation of p38 MAPK and c-Jun N-terminal kinase. J Mol Biol (2010) 1.07
Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia (2004) 1.07
m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate. J Biol Chem (2010) 1.07
Wnt5a directs polarized calcium gradients by recruiting cortical endoplasmic reticulum to the cell trailing edge. Dev Cell (2013) 1.07
Phosphoinositide binding to the substrate regulates susceptibility to proteolysis by calpain. J Biol Chem (2008) 1.03
Decision tree modeling predicts effects of inhibiting contractility signaling on cell motility. BMC Syst Biol (2007) 1.03
Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration. PLoS One (2014) 1.03
Calpain system protein expression in basal-like and triple-negative invasive breast cancer. Ann Oncol (2012) 1.02
Spatiotemporal regulation of Src and its substrates at invadosomes. Eur J Cell Biol (2012) 0.97
Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway. Mol Cancer Res (2010) 0.97
Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease. Int J Biochem Cell Biol (2010) 0.97
Calcium signals and calpain-dependent necrosis are essential for release of coxsackievirus B from polarized intestinal epithelial cells. Mol Biol Cell (2011) 0.93
Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer. J Cell Mol Med (2012) 0.91
Nox2 is required for macrophage chemotaxis towards CSF-1. PLoS One (2013) 0.89
Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla. BMC Cancer (2012) 0.88
Controlling multipotent stromal cell migration by integrating "course-graining" materials and "fine-tuning" small molecules via decision tree signal-response modeling. Biomaterials (2011) 0.87
Pathway analysis for genome-wide association study of basal cell carcinoma of the skin. PLoS One (2011) 0.85
Specific blockage of ligand-induced degradation of the Ah receptor by proteasome but not calpain inhibitors in cell culture lines from different species. Biochem Pharmacol (2007) 0.85
Learning and memory: an emergent property of cell motility. Neurobiol Learn Mem (2013) 0.84
The carboxyl tail of alpha-actinin-4 regulates its susceptibility to m-calpain and thus functions in cell migration and spreading. Int J Biochem Cell Biol (2013) 0.81
GIT1 is a novel MEK1-ERK1/2 scaffold that localizes to focal adhesions. Cell Biol Int (2009) 0.81
Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension. Am J Respir Cell Mol Biol (2016) 0.80
Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer. Breast Cancer Res (2014) 0.80
The anti-tumour compound, RH1, causes mitochondria-mediated apoptosis by activating c-Jun N-terminal kinase. Br J Pharmacol (2011) 0.79
Calpain activation by Wingless-type murine mammary tumor virus integration site family, member 5A (Wnt5a) promotes axonal growth. J Biol Chem (2010) 0.78
The calpain/calpastatin system has opposing roles in growth and metastatic dissemination of melanoma. PLoS One (2013) 0.77
Proteolysis of the human DNA polymerase delta smallest subunit p12 by μ-calpain in calcium-triggered apoptotic HeLa cells. PLoS One (2014) 0.77
Elevated calpain activity in acute myelogenous leukemia correlates with decreased calpastatin expression. Blood Cancer J (2012) 0.77
Genome-Wide Association Study for Identifying Loci that Affect Fillet Yield, Carcass, and Body Weight Traits in Rainbow Trout (Oncorhynchus mykiss). Front Genet (2016) 0.76
Modulation of Epidermal Growth Factor Stimulated ERK Phosphorylation and Cell Motility by Inositol Trisphosphate Kinase. J Pharm Sci Pharmacol (2014) 0.76
Tenascin-C Signaling in melanoma. Cell Adh Migr (2015) 0.75
The inhibition of calpains ameliorates vascular restenosis through MMP2/TGF-β1 pathway. Sci Rep (2016) 0.75
The calpain system as a potential target for pelvic muscle reinforcement. Cent European J Urol (2011) 0.75
Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature (1997) 8.52
Male attractiveness and differential testosterone investment in zebra finch eggs. Science (1999) 5.14
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene (2007) 4.80
Mathematical model for the effects of adhesion and mechanics on cell migration speed. Biophys J (1991) 4.68
A competency model for general practice: implications for selection, training, and development. Br J Gen Pract (2000) 4.25
Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci (2000) 4.13
Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol (1993) 3.74
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol (2000) 3.63
Integrin-cytoskeletal interactions in migrating fibroblasts are dynamic, asymmetric, and regulated. J Cell Biol (1993) 3.37
Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J (1996) 2.59
Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem (1997) 2.52
A dynamical model for receptor-mediated cell adhesion to surfaces. Biophys J (1987) 2.49
Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng (2000) 2.49
Migration of individual microvessel endothelial cells: stochastic model and parameter measurement. J Cell Sci (1991) 2.49
Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr Biol (1995) 2.47
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum (2010) 2.37
Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem (2000) 2.37
The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene (1993) 2.23
Physical and biochemical regulation of integrin release during rear detachment of migrating cells. J Cell Sci (1998) 2.23
A stochastic model for leukocyte random motility and chemotaxis based on receptor binding fluctuations. J Cell Biol (1988) 2.18
The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem (1991) 2.15
Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol (1994) 2.12
Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol (1998) 2.11
Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. J Cell Biol (2000) 2.09
Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol (2004) 2.08
A placebo-controlled trial of ketotifen (HC 20-511, Sandoz) in allergen induced asthma and comparison with disodium cromoglycate. Clin Allergy (1979) 1.98
Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc Natl Acad Sci U S A (1999) 1.96
Bioengineering models of cell signaling. Annu Rev Biomed Eng (2000) 1.96
Two psychological treatments for hypochondriasis. A randomised controlled trial. Br J Psychiatry (1998) 1.95
A survey of the demographics of blood use. Transfus Med (2007) 1.95
Kinetic analysis of F-actin depolymerization in polymorphonuclear leukocyte lysates indicates that chemoattractant stimulation increases actin filament number without altering the filament length distribution. J Cell Biol (1991) 1.94
Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J Biol Chem (2001) 1.92
Relationship between receptor/ligand binding affinity and adhesion strength. Biophys J (1993) 1.92
Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol (1996) 1.86
Integrin dynamics on the tail region of migrating fibroblasts. J Cell Sci (1996) 1.83
Beliefs about worry and intrusions: the Meta-Cognitions Questionnaire and its correlates. J Anxiety Disord (1997) 1.76
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer (2007) 1.75
Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol (1994) 1.75
Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol (2001) 1.74
Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J Biol Chem (1995) 1.72
Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner. J Cell Sci (1998) 1.72
A computational study of feedback effects on signal dynamics in a mitogen-activated protein kinase (MAPK) pathway model. Biotechnol Prog (2001) 1.71
Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol (2001) 1.68
Engineering epidermal growth factor for enhanced mitogenic potency. Nat Biotechnol (1996) 1.68
EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci (1998) 1.68
Receptor-mediated cell attachment and detachment kinetics. I. Probabilistic model and analysis. Biophys J (1990) 1.65
Expressed sequences from conidial, mycelial, and sexual stages of Neurospora crassa. Fungal Genet Biol (1997) 1.62
Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration. Biophys J (1999) 1.58
Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway. J Biol Chem (1999) 1.57
Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem (1999) 1.57
Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. J Theor Biol (1991) 1.57
EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metastasis (1996) 1.57
Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther (2005) 1.56
Autocrine loops with positive feedback enable context-dependent cell signaling. Am J Physiol Cell Physiol (2002) 1.55
Self-assembly of a beta-sheet protein governed by relief of electrostatic repulsion relative to van der Waals attraction. Biomacromolecules (2000) 1.54
IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. J Cell Biol (1999) 1.53
Spatial range of autocrine signaling: modeling and computational analysis. Biophys J (2001) 1.52
Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. Biotechnol Bioeng (2000) 1.50
A mathematical model for chemoattractant gradient sensing based on receptor-regulated membrane phospholipid signaling dynamics. Ann Biomed Eng (2001) 1.48
Kinetic analysis of chemotactic peptide receptor modulation. J Cell Biol (1982) 1.45
A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol (1996) 1.45
In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther (1996) 1.45
An unexpectedly rapid decline in the X-ray afterglow emission of long gamma-ray bursts. Nature (2005) 1.39
Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer (2007) 1.39
Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation. Nat Struct Biol (1999) 1.35
STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem (1996) 1.35
Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism. Mol Biol Cell (1996) 1.35
Quantitative analysis of the EGF receptor autocrine system reveals cryptic regulation of cell response by ligand capture. J Cell Sci (2001) 1.35
Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. J Biol Chem (1994) 1.35
Fatty acid-induced insulin resistance in adipocytes. Endocrinology (1997) 1.35
Specific adhesion of glycophorin liposomes to a lectin surface in shear flow. Biophys J (1990) 1.34
In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis (1995) 1.32
Receptor-mediated cell attachment and detachment kinetics. II. Experimental model studies with the radial-flow detachment assay. Biophys J (1990) 1.32
Physical modulation of intracellular signaling processes by locational regulation. Biophys J (1997) 1.32
Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells. J Biol Chem (2001) 1.32
Deconstructing (and reconstructing) cell migration. Microsc Res Tech (1998) 1.32
Tumor invasion as dysregulated cell motility. Semin Cancer Biol (2001) 1.31
"Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. Br Heart J (1992) 1.30
Biological surface engineering: a simple system for cell pattern formation. Biomaterials (1999) 1.29
Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology (1991) 1.27
Shaping up for shipping out: PLCgamma signaling of morphology changes in EGF-stimulated fibroblast migration. Cell Motil Cytoskeleton (1999) 1.27
Quantitative relationship among integrin-ligand binding, adhesion, and signaling via focal adhesion kinase and extracellular signal-regulated kinase 2. J Biol Chem (1999) 1.26
Integrin-cytoskeletal interactions in neuronal growth cones. J Neurosci (1995) 1.25
Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay. Int J Gynecol Cancer (2006) 1.25
A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin Cancer Res (1999) 1.25
New trends in photobiology. The interaction of UVA radiation with cultured cells. J Photochem Photobiol B (1990) 1.24
Mutagenesis by hydrogen peroxide treatment of mammalian cells: a molecular analysis. Carcinogenesis (1990) 1.24
Quantitative analysis of synthetic gene delivery vector design properties. Mol Ther (2001) 1.23
Comparison of BD Vacutainer SST Plus Tubes with BD SST II Plus Tubes for common analytes. Clin Chim Acta (2001) 1.22